États-Unis · Magazines éco · Markets Insider (Business Insider)

Big Pharma's Obesity Shopping Spree Is Moving Beyond GLP-1s. Palatin May Fit the Pattern (NASDAQ: PTN)

Publié par Markets Insider (Business Insider) · États-Unis il y a 2 h

WSW, NY, October 21st, 2026, FinanceWireRecent acquisitions and licensing deals reveal what drugmakers want next: different biology, better dosing and treatments that can...

Lire l'article complet sur Markets Insider (Business Insider) Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (markets.businessinsider.com)

Big Pharma's Obesity Shopping Spree Is Moving Beyond GLP-1s. Palatin May Fit the Pattern (NASDAQ: PTN)

À lire aussi

How to pay off debt: 10 strategies for 2026

Stolen SSN? A New Law Promises Faster Help From Social Security

Hackers Hijacked a System Retailers Trust. Now Staples Faces a $5 Million Loss

Microsoft and Alphabet object to blockchain versions of their shares—but their veto only goes so far

Boeing's largest 737 MAX jet wins FAA certification, clearing way for deliveries of 1,555 ordered planes

Nvidia Lines Up Six Suppliers To Expand AI Chip Capacity Through 2028

Big Pharma's Obesity Shopping Spree Is Moving Beyond GLP-1s. Palatin May Fit the Pattern (NASDAQ: PTN)

Partager

À lire aussi

How to pay off debt: 10 strategies for 2026

Stolen SSN? A New Law Promises Faster Help From Social Security

Hackers Hijacked a System Retailers Trust. Now Staples Faces a $5 Million Loss

Microsoft and Alphabet object to blockchain versions of their shares—but their veto only goes so far

Boeing's largest 737 MAX jet wins FAA certification, clearing way for deliveries of 1,555 ordered planes

Nvidia Lines Up Six Suppliers To Expand AI Chip Capacity Through 2028